Sandoz sued over sterile solution

23-06-2017

Biopharmaceutical company Omeros has filed a complaint against Sandoz for allegedly infringing its patent covering Omidria (phenylephrine and ketorolac).


Sandoz, Omeros, patent, ANDA, FDA, District Court for the District of New Jersey

LSIPR